share_log

Market-Moving News for December 18th

Benzinga ·  04:28

PLRZ: 282% | Polyrizon Secures GMP Manufacturing Partnership With Eurofins CDMO Amatsiaquitaine, Advancing Toward PL-14 Allergy Blocker Clinical Trial In 2025

CRVS: 24% | Corvus Pharmaceuticals shares are trading higher after the company announced it will report on December 18 interim data from its Phase 1 clinical trial evaluating Soquelitinib in patients with moderate to severe atopic dermatitis.

OKLO: 10% | Oklo And Switch Partner To Deploy 12 GW Of Advanced Nuclear Power

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment